What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials

Link to article at PubMed

Med (N Y). 2020 May 19. doi: 10.1016/j.medj.2020.04.002. Online ahead of print.


The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 there remains an urgent need for pharmacologic therapies to treat infected patients, minimize mortality, and decrease pressures on intensive care units and health systems and optimally, they should also decrease subsequent transmission.

PMID:32838354 | PMC:PMC7235589 | DOI:10.1016/j.medj.2020.04.002

Leave a Reply

Your email address will not be published. Required fields are marked *